View of Is there any place for the chimeric antibody against tumor necrosis factor (infliximab) in the treatment of patients with active ulcerative colitis?

Return to Article Details Is there any place for the chimeric antibody against tumor necrosis factor (infliximab) in the treatment of patients with active ulcerative colitis? Download Download PDF